Paragon Biosciences is more than an investment firm, though that’s certainly the backbone of the company. Jeff Aronin founded Paragon with the intention of helping innovative bioscience companies get their products to the patients in need of them. Paragon Biosciences has a unique approach in that it develops its companies based on an algorithm that addresses patient needs, while also looking at the nature of their illnesses. By taking this two-tier approach, they’re able to devise more promising methods of diagnosis and treatment.
Already, Paragon Biosciences oversees four separate companies that pride themselves on coming up with new solutions to seemingly insolvable medical problems. Castle Creek Pharmaceuticals (CCP) focuses its resources on developing new biopharmaceutical treatments for rare and serious skin conditions. Harmony Biosciences applies its own research toward treating serious sleep disorders and other conditions that affect the central nervous system. Meanwhile, Decade is another Paragon owned company, putting its efforts toward the alleviation of symptoms in Alzheimer’s patients. Finally, Precision BP works towards treating rare genetic oncological illnesses. Each one of these companies is driven by strong research and development departments that look for new and promising methods of treatment in their specific areas of interest.
Of course, the man behind Paragon Biosciences, Jeff Aronin, has a long history of developing innovative new approaches to unsolvable medical dilemmas. After spending two decades developing biotech innovations and applying them to the healthcare industry, Jeff knows what works and what doesn’t work.
Long ago, Mr. Aronin recognized the advantages of getting business investors together at the same table with scientific researchers. The result has been a total of 13 new drug approvals from the FDA, a number that exceeds any other biotech firm. This means Jeff Aronin and Paragon Biosciences is already changing millions of lives, giving patients new hope for successful treatment.
Jeff Aronin may find it rewarding to bring new treatments to the patients who need them, but he doesn’t stop there. He also works with up and coming entrepreneurs, eager to guide them towards achieving their own success (Weeklyopinion). Through his mentoring endeavors, Jeff Aronin is changing even more lives.